Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
Public ClinicalTrials.gov record NCT00054873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of tezacitabine when given alone or in combination with 5-fluorouracil (5-FU) to subjects who have advanced esophageal or gastric adenocarcinoma.
Study identification
- NCT ID
- NCT00054873
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2003
- Primary completion
- Not listed
- Completion
- Nov 30, 2004
- Last update posted
- Jul 10, 2006
2003 – 2004
United States locations
- U.S. sites
- 29
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| ACRC/Arizona Clinical Research Center | Tucson | Arizona | 85712 | — |
| Glendale Memorial Hospital | Glendale | California | 91204 | — |
| USC/Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| Tower Hematology Oncology Medical Group | Los Angeles | California | 90048 | — |
| Comprehensive Cancer Center at DRMC | Palm Springs | California | 92262 | — |
| Desert Regional Medical Center | Palm Springs | California | 92262 | — |
| Sharp Clinical Oncology Research | San Diego | California | 92123 | — |
| UCSF Comprehensive Cancer Center | San Francisco | California | 94115-1705 | — |
| Cancer Institute Medical Group | Santa Monica | California | 90404 | — |
| Denver VAMC | Denver | Colorado | 80220 | — |
| H. Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612-9497 | — |
| Memorial Regional Comprehensive Cancer Center | Weston | Florida | 33326 | — |
| Northwestern University, Feinberg School of Medicine, Division of Hematology/Oncology | Chicago | Illinois | 60611 | — |
| The University of Chicago | Chicago | Illinois | 60637 | — |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| LSU Health Sciences Center, Dept. of Medicine, Hematology/Oncology | Shreveport | Louisiana | 77130 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| University of Michigan Medical Center | Ann Arbor | Michigan | 48109-0922 | — |
| Josephine Ford Cancer Center, Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Kansas City Oncology and Hematology Group | Kansas City | Missouri | 64111 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| The Sarah Cannon Cancer Center, Tennessee Oncology | Nashville | Tennessee | 37203 | — |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232 | — |
| University of Texas, MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00054873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2006 · Synced Sep 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00054873 live on ClinicalTrials.gov.